School of Life Science and Biotechnology, Korea University, Seoul, 136-701 Republic of Korea ; Department of Bioplant, Hanmi Pharm. Co, Pyeongtaek, 451-805 Korea.
Department of Bioplant, Hanmi Pharm. Co, Pyeongtaek, 451-805 Korea.
Biomater Res. 2014 Jun 13;18:6. doi: 10.1186/2055-7124-18-6. eCollection 2014.
Hyaluronic acid (HA) is of importance due to its diverse applications in pharmaceuticals and medical devices such as dermal filler, adhesion barriers, carrier for cells and bioactive molecules as well as scaffold biomaterials for tissue engineering. Evaluations of purification and biocompatibility of HA are required for its applications to biomaterials.
After synthesizing HA by fermentation of streptococcus zooepidemicus for 25 hr, extensively purification of the fermented broth was performed to remove impurities using a filtration process for insoluble components and cells, and diverse adsorbents for soluble impurities. Its in vitro biocompatibility has been evaluated by measurement of cell counting and assay of cell live and dead. 60% yield of white HA powder was obtained, having 15-17 dL/g intrinsic viscosity with a molecular weight of approximately 1,000 kDa. While low molecular weight impurities and insoluble impurities were successfully removed using a ultrafiltration membrane with 50 KDa molecular weight cut, endotoxins, high molecular weight proteins and nucleic acids were removed from the broth by employing adsorbents such as alumina and activated carbons. Alumina showed the best results for the removal of endotoxins, all of the activated carbons were very effective in the removal of high molecular weight proteins and nucleic acids. The purified HA solution showed excellent cell compatibility with no cell damages as observed by both measurement of cell proliferation and observation of cell viability.
We obtained high molecular weight HA with excellent biocompatibility as judged by both measurement of cell proliferation and viability, indicating high possibility of its applications to biomaterials.
由于透明质酸(HA)在药物和医疗器械中的多种应用,如真皮填充剂、粘连屏障、细胞和生物活性分子的载体以及组织工程的支架生物材料,因此具有重要意义。HA 作为生物材料的应用需要对其纯化和生物相容性进行评估。
在链球菌发酵 25 小时后合成 HA,通过过滤过程去除不溶性成分和细胞以及多种可溶性杂质的吸附剂对发酵液进行广泛的纯化。通过细胞计数和死活细胞检测评估其体外生物相容性。获得了 60%的白色 HA 粉末产率,具有 15-17 dL/g 的特性粘度和大约 1000 kDa 的分子量。虽然使用分子量为 50 kDa 的超滤膜可以成功去除低分子量杂质和不溶性杂质,但通过使用氧化铝和活性炭等吸附剂可以从发酵液中去除内毒素、高分子量蛋白质和核酸。氧化铝在去除内毒素方面表现最佳,所有活性炭在去除高分子量蛋白质和核酸方面都非常有效。纯化的 HA 溶液显示出优异的细胞相容性,细胞增殖和细胞活力观察均未观察到细胞损伤。
我们获得了具有优异生物相容性的高分子量 HA,这可以通过细胞增殖和活力的测量来判断,表明其在生物材料中的应用具有很高的可能性。